All In Biotech

Drug Trial Radar · NCT04402489

Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoietic Protoporphyria or X-Linked Protoporphyria

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Adults and Adolescents With Erythropoietic Protoporphyria or X-Linked Protoporphyria

Last checked: Nov 20, 2026Latest source record: Dec 30, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 184 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

184

Actual

Start

Jun 1, 2020

Primary completion

Dec 14, 2021

Study completion Jul 26, 2022

Sponsor

Lead sponsor
Tanabe Pharma America, Inc.Industry
Sponsor type
Industry
First posted
May 26, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this study is to investigate the efficacy of MT-7117 on time to onset and severity of first prodromal symptoms (burning, tingling, itching, or stinging) associated with sunlight exposure in adults and adolescents with EPP or XLP aged 12-75.

Conditions

  • EPP
  • XLP

Interventions

  • PlaceboDrug

    Placebo

  • MT-7117 Low DoseDrug

    MT-7117 Low Dose

  • MT-7117 High DoseDrug

    MT-7117 High Dose

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Average Daily Sunlight Exposure Time (Minutes) to First Prodromal Symptom (Burning, Tingling, Itching, or Stinging) Associated With Sunlight Exposure Between 1 Hour Post Sunrise and 1 Hour Pre-sunset at Week 26 (Visit 7)Time frame: From 1 hour post-sunrise to 1 hour pre-sunset at Week 26 (Visit 7)

Locations

31 sites in 10 countries. Site status is shown where the registry gives one.

  • Marvel Clinical Research, LLC

    Huntington Beach, California

  • University Of Miami School Of Medicine, Center For Liver Diseases

    Miami, Florida

  • MetroBoston Clinical Partners, LLC

    Brighton, Massachusetts

  • Kansas City Research Institute

    Kansas City, Missouri

  • Icahn School of Medicine at Mount Sinai (ISMMS) - The Mount Sinai Hospital (MSH)

    New York, New York

  • Wake Forest University Baptist Health

    Winston-Salem, North Carolina

  • Remington-Davis Clinical Research

    Columbus, Ohio

  • Thomas Jefferson University

    Philadelphia, Pennsylvania

  • The University of Texas Medical Branch (UTMB)

    Galveston, Texas

  • University of Washington-Seattle Cancer Care Alliance

    Seattle, Washington

  • The Wesley Hospital

    Brisbane, Queensland, Australia

  • Royal Melbourne Hospital (RMH)

    Melbourne, Victoria, Australia

  • University of Alberta

    Edmonton, Alberta, Canada

  • Charite - Universitaetsmedizin Berlin

    Berlin, Germany

  • Westfaelische Wilhelms-Universitaet Muenster

    Münster, Northrhein Westalien, Germany

  • Azienda Ospedaliera Spedali Civili di Brescia-Universita degli Studi Di Brescia

    Brescia, Italy

  • Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico di Milano

    Milan, Italy

  • U.O.C. Medicina Interna Azienda ospedaliero Universitaria Policlinico di Modena

    Modena, Italy

  • I.F.O Hospital Centro Porfirie e Malattie Rare

    Rome, Italy

  • Kobe University Hospital

    Kobe, Hyōgo, Japan

  • Sophia Dermatology Clinic

    Kanazawa, Ishikawa-ken, Japan

  • Investigator site

    Sayama, Osaka, Japan

  • Osaka Medical College Hospital

    Takatsuki, Osaka, Japan

  • Tokyo Saiseikai Central Hospital

    Minato-ku, Tokyo, Japan

  • Toyama University Hospital

    Sugitani, Toyama, Japan

  • Haukeland University Hospital

    Bergen, Norway

  • Hospital Clínic de Barcelona

    Barcelona, Spain

  • Hospital Universitario 12 de Octubre

    Madrid, Spain

  • Karolinska University Hospital

    Stockholm, Sweden

  • Evelina London Children's Hospital - Guy's & St Thomas' NHS Foundation Trust

    London, United Kingdom

  • University of Manchester

    Salford, Manchester, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.